The University of Melbourne (UniMelb)

Australia

About

Established in 1853, the University of Melbourne is an international leader in research, learning and teaching — attracting students from more than 150 countries.

It is consistently ranked among the world’s leading universities, with international rankings placing it as number 1 in Australia and number 33 in the world (Times Higher Education World University Rankings 2015–2016).

The University of Melbourne’s success as a leading teaching and research organisation is based on the notion that our people are our point of difference. We strive to create and maintain a work environment which attracts and retains the best research workforce, including graduate researchers and professional staff who provide essential contributions to research.

Our academics are renowned researchers and industry leaders, recognised globally for their achievements. Our graduates are valued by employers across the world for their academic excellence, cross-cultural fluency, and active global citizenship.

Research at the University of Melbourne

Excellence in research is core to the University of Melbourne’s mission. The University is a globally-engaged, comprehensive, research-intensive university with the capacity to make significant contributions to global social, economic and environmental challenges.

The University of Melbourne is committed to nurturing scholarship, to developing new insights and promoting a wider understanding of the world in which we live. Through its ‘Research at Melbourne’ strategy, the University has committed to cherish and cultivate investigator-driven research in the fundamental enabling disciplines, while pursuing applied solutions to three Grand Challenges:

  • understanding our place and purpose
  • fostering health and wellbeing
  • supporting sustainability and resilience.

These Grand Challenges draw on the deep disciplinary expertise and scholarship of our researchers — who are working toward discoveries that contribute to the global reserve of knowledge, and inform major shifts in thinking. Importantly, the Grand Challenges are embedded across the University through its precincts and partnerships as well as through our international and graduate research training agenda.

The University of Melbourne retains sole responsibility for content © 2017 The University of Melbourne.

1 November 2017 - 31 October 2018

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for The University of Melbourne (UniMelb) published between 1 November 2017 - 31 October 2018 which are tracked by the Nature Index.

Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Note: Articles may be assigned to more than one subject area.

AC FC
488 96.05

Outputs by subject (FC)

Subject AC FC
Physical Sciences 163 19.30
Earth & Environmental Sciences 73 20.28
Life Sciences 231 44.58
Chemistry 63 22.14

Highlight of the month

New class of drug puts cancer cells to sleep

© KATERYNA KON/SCIENCE PHOTO LIBRARY/Getty

© KATERYNA KON/SCIENCE PHOTO LIBRARY/Getty

A new type of drug compound that puts cancer cells into a permanent sleep without damaging the cells’ DNA has shown promise in animal models of blood and liver cancers.

A team that included scientists from the University of Melbourne screened 243,000 compounds, looking for drugs that block KAT6A, a protein that when genetically depleted dramatically extends the life span of mice with lymphoma.

The researchers found one, which they chemically optimized to create two potent, selective inhibitors of KAT6A and KAT6B, enzymes that regulate the cell cycle by affecting when DNA is wound tightly on its spools.

The drugs selectively targeted liver cancer cells in zebrafish and arrested the progression of lymphoma in mice, with few side effects and little impact on healthy tissue. If human clinical trials give similar results, the compounds could offer “an entirely new weapon for fighting cancer,” said the University of Melbourne’s Tim Thomas in a press release.

Supported content

  1. Nature 560, 253–257 (2018). doi: 10.1038/s41586-018-0387-5

View the article on the Nature Index

See more research highlights from The University of Melbourne (UniMelb)

More research highlights from The University of Melbourne (UniMelb)

1 November 2017 - 31 October 2018

International vs. domestic collaboration by FC

  • 36.92% Domestic
  • 63.08% International

Note: Hover over the graph to view the percentage of collaboration.

Note: Collaboration is determined by the fractional count (FC), which is listed in parentheses.

Affiliated joint institutions and consortia

Return to institution outputs